Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny
About Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Gilead Sciences
1
Helsinn Healthcare SA
1
Clinical Trials at Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny
During the past decade, Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
2011-04-01
Completed
1,455
Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
2015-10-13
2019-05-15
Completed
432
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
2019-02-07
2026-12-19
Recruiting
3,400
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny"
#1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny
According to Clinical.Site data, the most researched conditions in "Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny" are
"Breast Cancer" (1 trials), "Chemotherapy-Induced Nausea and Vomiting" (1 trials), "Gastric Adenocarcinoma" (1 trials), "Hepatocellular Carcinoma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny" in a lesser frequency.
Clinical Trials Intervention Types at Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny
Most popular intervention types in "Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil" (1 trials), "5-fluorouracil" (1 trials), "Andecaliximab" (1 trials), "Atezolizumab" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny
The vast majority of trials in "Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny
Currently, there are NaN active trials in "Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".